Effectiveness of the Adjuvanted RSVPreF3 Vaccine in Preventing Major Adverse Cardiovascular Events and Severe Exacerbations of COPD and Asthma Among US Adults ≥ 60 Years of Age

Authors:
  • DSDavid Singer
    David Singer
  • ASAndrea Steffens
    Andrea Steffens
  • ABAmi R. Buikema
    Ami R. Buikema
  • KTKatherine Theiss-Nyland
    Katherine Theiss-Nyland
  • MFMaria João Fonseca
    Maria João Fonseca
  • SGSusan I. Gerber
    Susan I. Gerber
  • AKAlison Kawai
    Alison Kawai
  • MJMary G. Johnson
    Mary G. Johnson
  • RSRui Song
    Rui Song
  • SHSarah Hague
    Sarah Hague

Abstract
No abstract available
Funding Information
  • GlaxoSmithKline (300153)

This publication has 21 references indexed in Scilit: